Bioecological control of inflammatory bowel disease

被引:18
作者
Bengmark, Stig [1 ]
机构
[1] Univ Coll & Middlesex Sch Med, Dept Haematol, UCL, London WC1E 6HX, England
关键词
ulcerative colitis; Crohn's disease; probiotics; prebiotics; synbiotics; antioxidants;
D O I
10.1016/j.clnu.2006.10.001
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
It is today generally accepted, that the intestinal bacterial flora is deeply involved in the pathogenesis of human inflammatory bowel diseases (IBDs), although the exact presence of unwanted or lack of specific crucial bacteria are not yet known. Westerners lack to large extent important immunomodulatory and fibre-fermenting lactic acid bacteria (LAB), bacteria which are present in all with a more primitive rural lifestyle. Acute reduction of flora is observed in disease, including IBD, as well as in mental and physical stress. Some observations suggest the mucosa has lost its ability of holding back the pathogenic flora and prevent close contacts between resident microflora. and the epithelial. surface. Among the manifestations of IBD are increased inflammation and coagulability, impaired cellular membrane function, exaggerated nitric oxide production and impaired short-chain fatty acid production. Animal studies suggest, in addition to reduced flora, an intimate association with immunostimulatory DNA, malfunctioning trifoil factors, increased splanchnic metabolism and reduced availability of natural antioxidants. Treatment with plant fibres, antioxidants and sometimes probiotics have had limited success. The most dramatic effects are seen in the few cases where total faecal replacement (TFR) has been tried. The general experience this far is that the best effects are obtained with compositions of probiotics rather than with single LAB treatments. (c) 2006 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:169 / 181
页数:13
相关论文
共 122 条
[31]   Crohn's disease: a defensin deficiency syndrome? [J].
Fellermann, K ;
Wehkamp, J ;
Herrlinger, KR ;
Stange, EF .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (06) :627-634
[32]   Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis [J].
Fernández-Bañares, F ;
Hinojosa, J ;
Sánchez-Lombraña, JL ;
Navarro, E ;
Martínez-Salmerón, JF ;
García-Pugés, A ;
González-Huix, F ;
Riera, J ;
González-Lara, V ;
Domínguez-Abascal, F ;
Giné, JJ ;
Moles, J ;
Gomollón, F ;
Gassull, MA .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (02) :427-433
[33]  
Finegold S.M., 1983, HUMAN INTESTINAL MIC, P3
[34]   Curcumin blocks NF-κB and the motogenic response in Helicobacter pylori-infected epithelial cells [J].
Foryst-Ludwig, A ;
Neumann, M ;
Schneider-Brachert, W ;
Naumann, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (04) :1065-1072
[35]   Iron, anaemia, and inflammatory bowel diseases [J].
Gasche, C ;
Lomer, MCE ;
Cavill, I ;
Weiss, G .
GUT, 2004, 53 (08) :1190-1197
[36]   INFLAMMATORY BOWEL-DISEASE AND DOMESTIC HYGIENE IN INFANCY [J].
GENT, AE ;
HELLIER, MD ;
GRACE, RH ;
SWARBRICK, ET ;
COGGON, D .
LANCET, 1994, 343 (8900) :766-767
[37]   ANTAGONISTIC ACTION OF LACTOBACILLUS-ACIDOPHILUS TOWARD INTESTINAL AND FOODBORNE PATHOGENS IN ASSOCIATIVE CULTURES [J].
GILLILAND, SE ;
SPECK, ML .
JOURNAL OF FOOD PROTECTION, 1977, 40 (12) :820-823
[38]   Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial [J].
Gionchetti, P ;
Rizzello, F ;
Venturi, A ;
Brigidi, P ;
Matteuzzi, D ;
Bazzocchi, G ;
Poggioli, G ;
Miglioli, M ;
Campieri, M .
GASTROENTEROLOGY, 2000, 119 (02) :305-309
[39]   Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial [J].
Gionchetti, P ;
Rizzello, F ;
Helwig, U ;
Venturi, A ;
Lammers, KM ;
Brigidi, P ;
Vitali, B ;
Poggioli, G ;
Miglioli, M ;
Campieri, M .
GASTROENTEROLOGY, 2003, 124 (05) :1202-1209
[40]   Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans [J].
Gotteland, M ;
Cruchet, S ;
Verbeke, S .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (01) :11-17